These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15182272)
1. Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate. Wraight JM; Smith AD; Cowan JO; Flannery EM; Herbison GP; Taylor DR Respirology; 2004 Jun; 9(2):215-21. PubMed ID: 15182272 [TBL] [Abstract][Full Text] [Related]
2. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. Balkissoon R; Make B COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147 [TBL] [Abstract][Full Text] [Related]
3. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
4. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics. Ahmad Z; Singh SK J Asthma; 2010 Apr; 47(3):340-3. PubMed ID: 20394521 [TBL] [Abstract][Full Text] [Related]
5. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study. Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051 [TBL] [Abstract][Full Text] [Related]
6. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. Gelb AF; Karpel J; Wise RA; Cassino C; Johnson P; Conoscenti CS Pulm Pharmacol Ther; 2008 Aug; 21(4):630-6. PubMed ID: 18403223 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [TBL] [Abstract][Full Text] [Related]
8. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD. Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436 [TBL] [Abstract][Full Text] [Related]
9. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245 [TBL] [Abstract][Full Text] [Related]
10. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination. Angus R; Reagon R; Cheesbrough A Int J Clin Pract; 2005 Feb; 59(2):156-62. PubMed ID: 15854190 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma. Brookman LJ; Knowles LJ; Barbier M; Elharrar B; Fuhr R; Pascoe S Curr Med Res Opin; 2007 Dec; 23(12):3113-22. PubMed ID: 17999782 [TBL] [Abstract][Full Text] [Related]
12. Pupil blown by a puffer. Papalkar D; Sharma NS; Ooi JL; Sharma S; Francis IC Lancet; 2004 Jul 31-Aug 6; 364(9432):415; author reply 415. PubMed ID: 15288735 [No Abstract] [Full Text] [Related]
13. Laryngeal findings in users of combination corticosteroid and bronchodilator therapy. Mirza N; Kasper Schwartz S; Antin-Ozerkis D Laryngoscope; 2004 Sep; 114(9):1566-9. PubMed ID: 15475783 [TBL] [Abstract][Full Text] [Related]
14. Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. Jarjour NN; Wilson SJ; Koenig SM; Laviolette M; Moore WC; Davis WB; Doherty DE; Hamid Q; Israel E; Kavuru MS; Ramsdell JW; Tashkin DP; Reilly DS; Yancey SW; Edwards LD; Stauffer JL; Dorinsky PM; Djukanovic R J Allergy Clin Immunol; 2006 Jul; 118(1):44-52. PubMed ID: 16815137 [TBL] [Abstract][Full Text] [Related]
15. Ipratropium for acute asthma in adults. Holten KB Can Fam Physician; 2000 Dec; 46():2406-7. PubMed ID: 11153407 [No Abstract] [Full Text] [Related]
16. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response. Peters S Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066 [TBL] [Abstract][Full Text] [Related]
17. The influence of ipratropium bromide in the recovery phase of methacholine induced-bronchospasm. Sposato B; Mariotta S; Ricci A; Bruno P; Terzano C; Mannino F Eur Rev Med Pharmacol Sci; 2005; 9(2):117-23. PubMed ID: 15945501 [TBL] [Abstract][Full Text] [Related]
18. Is there a problem with inhaled long-acting beta-adrenergic agonists? Nelson HS J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577 [TBL] [Abstract][Full Text] [Related]
19. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231 [TBL] [Abstract][Full Text] [Related]
20. In children hospitalized for asthma exacerbations, does adding ipratropium bromide to albuterol and corticosteroids improve outcome? Hayday K; Stevermer JJ J Fam Pract; 2002 Mar; 51(3):280. PubMed ID: 11978242 [No Abstract] [Full Text] [Related] [Next] [New Search]